New Zealand - Hospital Average Length of Stay for Dermatitis, Eczema and Papulosquamous Disorders Cases
Since 2014, New Zealand Hospital Average Length of Stay for Dermatitis, Eczema and Papulosquamous Disorders Cases fell by 1.2% year on year. In 2019, the country was ranked number 30 comparing other countries in Hospital Average Length of Stay for Dermatitis, Eczema and Papulosquamous Disorders Cases at 3.3 Days. New Zealand is overtaken by Ireland, which was ranked number 29 at 3.4 Days and is followed by Mexico at 3 Days. Germany ranked the highest with 11 Days in 2019, a fall of 1.8% compared to 2018. Portugal, Czech Republic and Iceland respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +4% per year, while Switzerland witnessed the worst performance at -6.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 3.30 |
| 2018 | 3.40 |
| 2017 | 3.40 |
| 2016 | 3.50 |
| 2015 | 3.40 |
How does New Zealand rank in Hospital Average Length of Stay for Dermatitis, Eczema and Papulosquamous Disorders Cases?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
11.00 | 2019 | -1.8 % | -1.9 % | View data | |
| 2 |
#2
Portugal
|
9.00 | 2018 | NA | -1.3 % | View data | |
| 29 |
#29
Ireland
|
3.40 | 2019 | -5.6 % | -2.2 % | View data | |
| 30 |
#30
New Zealand
|
3.30 | 2019 | -2.9 % | -1.2 % | View data | |
| 31 |
#31
Chile
|
3.00 | 2019 | -3.2 % | -3.0 % | View data | |